Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Roche discloses new 5-HT2B antagonists

Feb. 13, 1998

No Comments

Antipsychotic drugs in development at Janssen

Feb. 13, 1998

No Comments

DuPont Merck claims new CRF antagonists

Feb. 13, 1998

No Comments

Neurocrine Biosciences and Rigel collaborate on gliosis inhibitors

Feb. 12, 1998

No Comments

U.S. clearance for naratriptan

Feb. 12, 1998

No Comments

Potential new antimigraine agents in development at Allelix

Feb. 12, 1998

No Comments

Warning issued for Duract related to potential hepatotoxicity

Feb. 11, 1998

No Comments

Wyeth-Ayerst describes synthesis and pharmacological profile of new agent for stroke

Feb. 11, 1998

No Comments

Solvay and Elan to codevelop new formulation of fluvoxamine

Feb. 10, 1998

No Comments

Novel antidepressant completes phase I trials

Feb. 10, 1998

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Neurology/psychiatric
RSS

Roche discloses new 5-HT2B antagonists

Antipsychotic drugs in development at Janssen

DuPont Merck claims new CRF antagonists

Neurocrine Biosciences and Rigel collaborate on gliosis inhibitors

U.S. clearance for naratriptan

Potential new antimigraine agents in development at Allelix

Warning issued for Duract related to potential hepatotoxicity

Wyeth-Ayerst describes synthesis and pharmacological profile of new agent for stroke

Solvay and Elan to codevelop new formulation of fluvoxamine

Novel antidepressant completes phase I trials

Today's news in brief

Today's news in brief

Enhanced Cognition: Lewy body dementia phase II pumps stock

Second insulin receptor offers new therapeutic avenues

Experimental mRNA gene therapy suppresses preeclampsia in mice

Neurology/psychiatric RSS

Neurology/psychiatric
RSS